Benchmarks ended the first trading session of the week in the red led by losses in biotech shares. Meanwhile, investors refrained from placing big bets ahead of the Federal Reserve meeting, which begins today. Investors also kept an eye on first quarter earnings results.For a look at the issues currently facing the markets, make sure to read today’s Ahead of […]
Benchmarks finished Tuesday’s trading session mostly lower following a mixed bag of earnings reports. While, a handful of discouraging quarterly results dragged the Dow and the S&P 500 down, the Nasdaq bucked the trend banking on a new deal in the biotechnology sector.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
